ESTRELLA IMMUNOPHARMA, INC. Taxes Payable, Current
ESTRELLA IMMUNOPHARMA, INC. (ESLA) had Taxes Payable, Current of $50 as of 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:TaxesPayableCurrent · last filed 2026-03-18
- 2025-03-31: Taxes Payable, Current $50.00.
- 2024-12-31: Taxes Payable, Current $50.00.
- 2024-09-30: Taxes Payable, Current $40.74K.
- 2024-06-30: Taxes Payable, Current $40.74K.
| Period end | Taxes Payable, Current |
|---|---|
| 2025-03-31 | $50.00 10-Q · filed 2025-05-14 |
| 2024-12-31 | $50.00 10-K · filed 2026-03-18 |
| 2024-09-30 | $40.74K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $40.74K 10-KT · filed 2025-03-25 |
| 2024-03-31 | $40.72K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $40.72K 10-Q · filed 2024-02-14 |
| 2023-06-30 | $61.64K 10-Q · filed 2023-08-01 |
| 2022-12-31 | $51.18K 10-Q · filed 2023-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |